Cite
HARVARD Citation
Banna, G. et al. (n.d.). Baseline neutrophil-to-lymphocyte ratio and PD-L1 expression level or LDH value may predict outcome of patients with high PD-L1 advanced non-small cell lung cancer treated with first-line pembrolizumab. Lung cancer. pp. S58-S59. [Online].